The ENHANCE Project Toolkit
Mobile Health Strategies to Support Longitudinal Engagement in Comprehensive, Community-based Prevention Services for People Who Use Drugs (Aim 3)
연구 개요
상세 설명
As a pilot study, this study is not designed to rigorously evaluate the effect of the intervention (i.e., health-related biomedical or behavioral outcome) on participants. Rather, the sample size will allow determination of feasibility, acceptability, appropriateness, and secondarily, will allow quantification of preliminary effect size to aid in future trial planning. After enrolling in the study, participants will receive a mobile phone with an unlimited data plan. After receiving the phone, participants will receive a brief orientation to a bundle of phone and internet-based overdose prevention tools. This includes overdose crisis hotlines, mail-order overdose prevention supplies, and a mobile health app that has been adapted for people who use drugs to support self-determined motivation for reaching goals through educational content, social engagement, and peer-to-peer support. Each month for 6 months, participants will also complete a 20-30 minute survey evaluating the primary and secondary outcomes (described below) and use of each phone and internet-based tool that is part of the enhanced harm reduction bundle. 25 participants will also be invited to complete a 45-60 minute semi-structured in-depth interview about their experience participating in the study and use of the phone- and internet-based tools. Primary analyses will seek to describe the feasibility, acceptability, and appropriateness of the overdose prevention service model. Secondarily, changes in overdose risk behaviors and experiences over the 6-month study period relative to baseline will be analyzed.
Primary Objective: to evaluate feasibility, appropriateness, and acceptability of an enhanced harm reduction service model incorporating internet and/or mobile health tools to reduce overdose risk for people who use opioid and/or stimulant drugs.
Secondary Objective: to understand overdose risk behaviors before and after the intervention.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Research Team
- 전화번호: (608) 572-3514
- 이메일: enhance@medicine.wisc.edu
연구 장소
-
-
Wisconsin
-
Madison, Wisconsin, 미국, 53792
- 모병
- UW School of Medicine and Public Health
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria (Pilot Participant):
- Be at least 18 years old
- Be able to read and write in English
Report drug use in the past 30 days, defined as
- Any use of illicit stimulants, opioids, OR
- Use of prescription opioids by a route other than "by mouth/swallowed"
- Additionally report recent drug use of at least twice in the past 7 days
Have NOT used any of the following harm reduction services in the past 6 months:
- In-person community-based prevention services for people who use drugs
- Overdose crisis hotlines
- Online mail-order prevention supply delivery
- Apps for supporting addiction treatment or recovery
Inclusion Criteria (Peer Mentor Participant):
- Be at least 18 years old
- Be able to read and write in English
- Have served as a member of the existing Community Leadership Team.
Exclusion Criteria:
- Are under the age of 18
- Have impaired decision making capacity at the time of screening
Do not have the ability to participate in screening and enrollment activities in any one of the following ways:
- Traveling to their nearest participating Vivent Health health center
- Coordinating a visit with the Vivent Health harm reduction mobile unit
- Accessing and completing the online screening survey on a personal wifi/internet enabled device
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 장치 타당성
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Pilot Participants
People who use opioid and/or stimulant drugs and are disconnected from harm reduction services.
|
Mobile health app, bundled with other harm reduction internet and phone resources
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Acceptability of Intervention Measure (AIM)
기간: up to 6 months
|
The Acceptability of Intervention Measure (AIM) measures intervention acceptability with 4 items ranked on a 5-point Likert-type scale.
Participants will be asked the 4-item questionnaire for each tool offered in the bundle (3).
Scores are averaged across the measure for each tool and subsequently scores for individual tools will be summed to generate a composite acceptability score of the program.
Scores can range from 3-15, with higher scores meaning higher acceptability of the intervention
|
up to 6 months
|
|
Intervention Appropriateness Measure (IAM)
기간: up to 6 months
|
The Intervention Appropriateness Measure (IAM) measures intervention appropriateness with 4 items ranked on a 5-point Likert-type scale.
Participants will be asked the 4-item questionnaire for each tool offered in the bundle (3).
Scores are averaged across the measure for each tool and subsequently scores for individual tools will be summed to generate a composite appropriateness score of the program.
Scores can range from 3-15, with higher scores meaning higher appropriateness of the intervention.
|
up to 6 months
|
|
Feasibility of Intervention Measure (FIM)
기간: up to 6 months
|
The Feasibility of Intervention Measure (FIM) measures intervention feasibility with 4 items ranked on a 5-point Likert-type scale.
Participants will be asked the 4-item questionnaire for each tool offered in the bundle (3).
Scores are averaged across the measure for each tool and subsequently scores for individual tools will be summed to generate a composite feasibility score of the program.
Scores can range from 3-15, with higher scores meaning higher feasibility of the intervention.
|
up to 6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in the Number of Risk Days from baseline to 6 months
기간: baseline, 6 months
|
This data will be collected using the Overdose Risk Behavior Scale (ORBS) instrument which provides a comprehensive index of proximal opioid-related overdose risks.
At baseline and study completion, participants will complete the ORBS assessment.
The ORBS assessment will be administered to assess the potential effect of the intervention on the frequency of overdose risk behaviors.
The average change in the self reported risk days on this instrument from baseline to six months will be reported as the outcome.
|
baseline, 6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Ryan Westergaard, MD, PhD, MPH, UW School of Medicine and Public Health
- 수석 연구원: Rachel Gicquelais, PhD, MPH, UW School of Medicine and Public Health
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2026-0408
- Protocol Version 3/13/26 (기타 식별자: UW- Madison)
- R01DA057645-02 (미국 NIH 보조금/계약)
- SMPH | Population Health (기타 식별자: UW Madison)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .